32.39
0.67 (2.11%)
| 前收盘价格 | 31.72 |
| 收盘价格 | 31.73 |
| 成交量 | 921,281 |
| 平均成交量 (3个月) | 1,595,141 |
| 市值 | 1,980,584,448 |
| 价格/销量 (P/S) | 5.52 |
| 股市价格/股市净资产 (P/B) | 4.50 |
| 52周波幅 | |
| 利润日期 | 2 Feb 2026 |
| 营业毛利率 | -54.98% |
| 营业利益率 (TTM) | -44.79% |
| 稀释每股收益 (EPS TTM) | -3.25 |
| 季度收入增长率 (YOY) | 23.20% |
| 总债务/股东权益 (D/E MRQ) | 18.25% |
| 流动比率 (MRQ) | 4.51 |
| 营业现金流 (OCF TTM) | -56.11 M |
| 杠杆自由现金流 (LFCF TTM) | -16.89 M |
| 资产报酬率 (ROA TTM) | -15.04% |
| 股东权益报酬率 (ROE TTM) | -38.22% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看涨 | 看涨 |
| Diagnostics & Research (全球的) | 看涨 | 看涨 | |
| 股票 | Twist Bioscience Corporation | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.38 |
|
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 1.98% |
| 机构持股比例 | 115.15% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 43.00 (TD Cowen, 32.76%) | 购买 |
| 中 | 41.00 (26.58%) | |
| 低 | 39.00 (Barclays, 20.41%) | 购买 |
| 平均值 | 41.00 (26.58%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 31.17 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| TD Cowen | 08 Jan 2026 | 43.00 (32.76%) | 购买 | 32.39 |
| Barclays | 15 Dec 2025 | 39.00 (20.41%) | 购买 | 31.07 |
| 17 Nov 2025 | 37.00 (14.23%) | 购买 | 26.46 | |
| Stephens & Co. | 04 Nov 2025 | 41.00 (26.58%) | 购买 | 30.06 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合